Matches in SemOpenAlex for { <https://semopenalex.org/work/W2779905914> ?p ?o ?g. }
- W2779905914 endingPage "10933" @default.
- W2779905914 startingPage "10920" @default.
- W2779905914 abstract "Polo-like kinases (Plks) define a highly conserved family of Ser/Thr kinases with crucial roles in the regulation of cell division. Here we show that Plk1 is cleaved by caspase 3, but not by other caspases in different hematopoietic cell lines treated with competitive inhibitors of the ATP-binding pocket of Plk1. Intriguingly, Plk1 was not cleaved in cells treated with Rigosertib, a non-competitive inhibitor of Plk1, suggesting that binding of the inhibitor to the ATP binding pocket of Plk1 triggers a conformational change and unmasks a cryptic caspase 3 cleavage site on the protein. Cleavage occurs after Asp-404 in a DYSD/K sequence and separates the kinase domain from the two PBDs of Plk1. All Plk1 inhibitors triggered G2/M arrest, activation of caspases 2 and 3, polyploidy, multiple nuclei and mitotic catastrophe, albeit at higher concentrations in the case of Rigosertib. Upon BI-2536 treatment, Plk1 cleavage occurred only in the cytosolic fraction and cleaved Plk1 accumulated in this subcellular compartment. Importantly, the cleaved N-Terminal fragment of Plk1 exhibited a higher enzymatic activity than its non-cleaved counterpart and accumulated into the cytoplasm conversely to the full length and the C-Terminal Plk1 fragments that were found essentially into the nucleus. Finally, the DYSD/K cleavage site was highly conserved during evolution from c. elegans to human. In conclusion, we described herein for the first time a specific cleavage of Plk1 by caspase 3 following treatment of cancer cells with ATP-competitive inhibitors of Plk1." @default.
- W2779905914 created "2018-01-05" @default.
- W2779905914 creator A5004100578 @default.
- W2779905914 creator A5007084558 @default.
- W2779905914 creator A5011814935 @default.
- W2779905914 creator A5017594953 @default.
- W2779905914 creator A5029645734 @default.
- W2779905914 creator A5034528977 @default.
- W2779905914 creator A5035351772 @default.
- W2779905914 creator A5036225674 @default.
- W2779905914 creator A5037025946 @default.
- W2779905914 creator A5037717599 @default.
- W2779905914 creator A5039959145 @default.
- W2779905914 creator A5049144741 @default.
- W2779905914 creator A5051365781 @default.
- W2779905914 creator A5054101486 @default.
- W2779905914 creator A5059182889 @default.
- W2779905914 creator A5059278546 @default.
- W2779905914 creator A5090083053 @default.
- W2779905914 date "2017-12-23" @default.
- W2779905914 modified "2023-10-11" @default.
- W2779905914 title "ATP-competitive Plk1 inhibitors induce caspase 3-mediated Plk1 cleavage and activation in hematopoietic cell lines" @default.
- W2779905914 cites W1851477645 @default.
- W2779905914 cites W1968438075 @default.
- W2779905914 cites W1973908775 @default.
- W2779905914 cites W1974937620 @default.
- W2779905914 cites W1987786553 @default.
- W2779905914 cites W1988974499 @default.
- W2779905914 cites W1998404806 @default.
- W2779905914 cites W2010919165 @default.
- W2779905914 cites W2015347444 @default.
- W2779905914 cites W2033408779 @default.
- W2779905914 cites W2037874673 @default.
- W2779905914 cites W2045510992 @default.
- W2779905914 cites W2048551141 @default.
- W2779905914 cites W2050960215 @default.
- W2779905914 cites W2059676290 @default.
- W2779905914 cites W2069449346 @default.
- W2779905914 cites W2074730820 @default.
- W2779905914 cites W2077936067 @default.
- W2779905914 cites W2095280226 @default.
- W2779905914 cites W2101725260 @default.
- W2779905914 cites W2113517398 @default.
- W2779905914 cites W2140364596 @default.
- W2779905914 cites W2146588049 @default.
- W2779905914 cites W2154745055 @default.
- W2779905914 cites W2168576472 @default.
- W2779905914 cites W2254621691 @default.
- W2779905914 cites W2278688270 @default.
- W2779905914 cites W2294083716 @default.
- W2779905914 cites W2318196164 @default.
- W2779905914 cites W2329549346 @default.
- W2779905914 cites W2340438210 @default.
- W2779905914 cites W2467902526 @default.
- W2779905914 cites W2468672251 @default.
- W2779905914 cites W2549761003 @default.
- W2779905914 cites W2593984201 @default.
- W2779905914 cites W2606364680 @default.
- W2779905914 cites W2607555575 @default.
- W2779905914 cites W2613163105 @default.
- W2779905914 cites W2621289937 @default.
- W2779905914 doi "https://doi.org/10.18632/oncotarget.23650" @default.
- W2779905914 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5834281" @default.
- W2779905914 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29541386" @default.
- W2779905914 hasPublicationYear "2017" @default.
- W2779905914 type Work @default.
- W2779905914 sameAs 2779905914 @default.
- W2779905914 citedByCount "3" @default.
- W2779905914 countsByYear W27799059142018 @default.
- W2779905914 countsByYear W27799059142021 @default.
- W2779905914 crossrefType "journal-article" @default.
- W2779905914 hasAuthorship W2779905914A5004100578 @default.
- W2779905914 hasAuthorship W2779905914A5007084558 @default.
- W2779905914 hasAuthorship W2779905914A5011814935 @default.
- W2779905914 hasAuthorship W2779905914A5017594953 @default.
- W2779905914 hasAuthorship W2779905914A5029645734 @default.
- W2779905914 hasAuthorship W2779905914A5034528977 @default.
- W2779905914 hasAuthorship W2779905914A5035351772 @default.
- W2779905914 hasAuthorship W2779905914A5036225674 @default.
- W2779905914 hasAuthorship W2779905914A5037025946 @default.
- W2779905914 hasAuthorship W2779905914A5037717599 @default.
- W2779905914 hasAuthorship W2779905914A5039959145 @default.
- W2779905914 hasAuthorship W2779905914A5049144741 @default.
- W2779905914 hasAuthorship W2779905914A5051365781 @default.
- W2779905914 hasAuthorship W2779905914A5054101486 @default.
- W2779905914 hasAuthorship W2779905914A5059182889 @default.
- W2779905914 hasAuthorship W2779905914A5059278546 @default.
- W2779905914 hasAuthorship W2779905914A5090083053 @default.
- W2779905914 hasBestOaLocation W27799059141 @default.
- W2779905914 hasConcept C146276462 @default.
- W2779905914 hasConcept C1491633281 @default.
- W2779905914 hasConcept C151730666 @default.
- W2779905914 hasConcept C153911025 @default.
- W2779905914 hasConcept C175156509 @default.
- W2779905914 hasConcept C184235292 @default.
- W2779905914 hasConcept C185592680 @default.
- W2779905914 hasConcept C190283241 @default.
- W2779905914 hasConcept C29537977 @default.